Using MIDD and Model Integrated Evidence to Support Generic Drug Development and Assessment

preview_player
Показать описание
Presented at SLP MIDD+ Virtual Conference March 3-4, 2021
  1. Simulations Plus, Inc.
  2. SLP MIDD
  3. generic drug development
  4. model-informed drug development
  5. U.S. FDA
Рекомендации по теме
Using MIDD and 0:29:55

Using MIDD and Model Integrated Evidence to Support Generic Drug Development and Assessment

Model-Integrated Evidence for 0:50:27

Model-Integrated Evidence for Generic Drug Development – Session 1B

Model-Integrated Evidence for 1:01:02

Model-Integrated Evidence for Generic Drug Development – Session 1C

How to Demonstrate 0:58:30

How to Demonstrate Virtual Bioequivalence for Complex Dermal Generic Drugs

Pharmacology and Pharmacometrics 0:51:17

Pharmacology and Pharmacometrics using Pumas

The Role of 0:33:59

The Role of MIDD in Drug Development for COVID-19

MIDD Training Module 0:51:00

MIDD Training Module 4 – Foundation to Model Informed Drug Development and Model Interconnectedness...

Model Informed Drug 0:15:51

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Value Focused MIDD: 0:03:16

Value Focused MIDD: Influenza Model-informed Drug Development Program

The benefits of 0:03:03

The benefits of using modeling and simulation in drug development

Regulatory Perspectives for 0:22:52

Regulatory Perspectives for Reliable Model Informed Drug Development (MIDD)

How Can Model 0:43:49

How Can Model Informed Drug Development Impact Your Program?

Model Informed Drug 0:31:10

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Strategic Implementation of 1:12:39

Strategic Implementation of Model-informed Drug Development (MIDD) for Regulatory Success

Module 6 – 1:29:45

Module 6 – Applying MIDD Strategies to Decision-Making

International Perspectives on 2:03:26

International Perspectives on Model-Informed Precision Dosing: From the Data to the Patients

A Best Practice 0:55:39

A Best Practice Framework for Applying PBPK Modeling to Pediatric Drug Development

Pharmacometrics in Phase 0:20:56

Pharmacometrics in Phase 3 – Data Integration and Analysis to Support Dose and Labeling for the NDA...

Quantitative Methods and 0:14:28

Quantitative Methods and Modeling (29of35) Complex Generics – Sep. 25-26, 2019

Clinical Track: Update 0:27:04

Clinical Track: Update on MIDD Program within the FDA

Keynote: Modeling and 0:44:21

Keynote: Modeling and Simulation to Guide Dose... | Husain Attarwala (Moderna) | JuliaCon 2022

Project Dontabhaktuni Hosted 1:21:49

Project Dontabhaktuni Hosted - Model-Informed Drug Development (MIDD) Workshop by Dr. Rick Lalonde

MIDD Training Module 0:37:46

MIDD Training Module 1

MIDD Training OVERVIEW 0:16:45

MIDD Training OVERVIEW